Blog / Archives
Another Good Week for Biopharma and Diagnostics Stocks: Innovation is Driving Gains-Update-2 Rotation day
Update-2 4/29 12:15p Mid-day trading -Healthcare weak as Investors rebalance to other sectors. Gilead Sciences (GILD) up over 6% and. boosts overall market with positive remdesivir data. NAZ up...
Volatile Coronavirus Stock Plays-Update and Summary April 23 GILD ?
Coronavirus (COVID-19) is an infectious disease currently spreading across the globe. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover....
Biotech Movers on a Roller Coaster Week as Coronavirus Speculation Ramps Up…Update-9 on March 30…major rally
3/30 11;30a Major news on COVID-19 diagnostics spark rally. Abbott launches 5 minute test. ABT up 7.28% ,JNJ up 6.8%, all large caps up, IBB up 2.55, XBI up 1.61%. Risk reward still looks good for...
Innovation Drives Biotech Stocks-Time to Nibble for Longer Term…Update-1 rally time
Update-1 nice broad biotech rally on stimulus hopes with biotech now seen as possible solution...
Biotech Stocks Mixed But Outperform the Market on a Down Day…Updates-BMRN GNMK REGN TDOC
2/28 10:15a XBI down to $86 level. Looking today to see what to buy. Bought VCYT yesterday at $23+ GNMK up 39% to $5 handle. Diagnostic and tools sector could be the place to look for buys but...
Stealth Drought Hits Sierras and California–April 12 heavy rains and snow eases drought risk
April 12 A Very Wet Spring Eases Drought Risk (data coming with 2.66 inches in April) Stealth Drought Hits Sierra Nevada in 2020 Dry Spell Yet Ahead But Previous Wet Years Have Allayed Concerns. I...
Raygent Focus Stocks -2020: Bristol-Myers, (BMY), Glaukos (GKOS),Teledoc (TDOC)…Update-2
Update-2 Mid-day trading 2/21 NAZ down 1.14%-Biotech stocks held their levels on a down day. Most large cap Raygent focus stocks are in green: ABBV,BMY,GILD up 4%, RHHBY. Mid-caps are mixed but...
Large Cap Biopharmaceutical Companies-Metrics and Valuations…BMY VRTX
Large Cap Biopharmaceutical Companies - Q1 2020 Update The IBB is at $122.69 near the 52 week high but short of 5 year high of $132.53 from Jy '15. FWD PEs of sector are still lower than the market...
Biotech Reversal Off 2020 Bottom But Within Trading Range: Update-2.. Abbvie (ABBV)
Update-2 2/10...Rally has expanded to mid-caps:ALNY ACAD GWPH ICPT SRPT Etc. ======= Update-1 2/7. 2p ...Abbvie (ABBV) Another one of our top large cap picks ABBV is up 6% o the $92 handle as of...
Bearish Pattern Emerging for Biotech-Geopolitical News Overwhelms Market…Update-1
Update-1 2/3...3:30p EST... Biopharma stocks firm up after a bad week Large caps are strong with Gilead Sciences (GILD) up over 5% on a story about an experimental antiviral therapy for...